<?xml version="1.0" encoding="UTF-8"?>
<p>SARS‐CoV‐2 infection is associated with a variety of pro‐inflammatory mediators that may play important roles in the pathophysiology of cardiac and arrhythmic complications. In a single center study
 <xref rid="jce14479-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref> cardiac injury was observed in 19% of hospitalized patients with COVID‐19, and it was associated with higher risk of in‐hospital mortality. Therefore, it is plausible that these patients have an even higher risk of cardiac arrhythmias.
</p>
